Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Chronic DiseaseEndocrine System DiseaseCardiovascular DiseaseRespiratory Tract DiseaseCNS Metabolic Disorders

Interventions

OTHER

Observation

Observation and evaluation of care provided to patients that received DNA tests to determine metabolic pathways.

Trial Locations (1)

Sevierville Foot and Ankle Clinic, Sevierville